Keyword: Emory University

Instead of seeking the underlying cause of a group of symptoms, scientists started with a mutation and then tracked down people who have it.

Checkpoint inhibitors like Merck’s Keytruda don’t work for many patients, and no one knows exactly why. Now, scientists at Emory say they’ve found a clue.

Scientists at Emory University’s Winship Cancer Institute are on a mission to unlock the mysteries of lung cancer cells that have long been thought to be unresponsive to any drug therapy. So they’ve developed what they call a “spiderweb of interactions” between proteins in those cancer cells, and they’re using the data to figure out how to target cancer mutations in the lung.

In a small study involving 20 patients, a team at Emory University says they successfully used cryoablation therapy--cold blasts--to successfully treat phantom limb pain. "Until now, individuals...